Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT05855759

Acellular Matrix From Human Dermis in Combination With Orthobiologic Stimuli for Augmentation of Massive Rotator Cuff Tears

Led by Istituto Ortopedico Rizzoli · Updated on 2026-02-19

72

Participants Needed

1

Research Sites

127 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The use of biologic acellular matrices for the surgical augmentation of rotator cuff lesions has greatly expanded inrecent years. The study team patented a method for removing cells from human dermis (Acellular Dermal Matrix), maintaining unaltered biological and structural integrity. Acellular Dermal Matrix has been succesfully used for rotator cuff surgical repair augmentation beside in a limited number of patients. The aim of the project is to demonstrate the therapeutical efficacy of this strategy in patients affected by rotator cuff massive tears. Acellular Dermal Matrix will be also combined with autologous orthobiologics.

CONDITIONS

Official Title

Acellular Matrix From Human Dermis in Combination With Orthobiologic Stimuli for Augmentation of Massive Rotator Cuff Tears

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients affected by large to massive lesion according to Gerber involving supraspinatus and infraspinatus tendons
  • Tendon retraction <=3 according to Thomazeau
  • Fatty degeneration <=3 according to Goutallier
  • Possibility to obtain tendon reduction
  • Pre-operative Magnetic Resonance Imaging
  • Ability to read, understand and complete outcome scores
Not Eligible

You will not qualify if you...

  • Patients affected by osteoarthritic degeneration
  • Frozen shoulder
  • Symptomatic acromioclavicular arthritis
  • Revision surgeries
  • Inability to cope with post-operative rehabilitation regimen
  • Autoimmune connective tissue disease
  • Current or past hematological disorders
  • Comorbidities affecting healing
  • Active infections
  • Cancers
  • Pregnancy and lactation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istituto Ortopedico Rizzoli

Bologna, BO, Italy, 40136

Actively Recruiting

Loading map...

Research Team

M

Marco Cavallo, MD

CONTACT

M

Matilde Tschon, BSC

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here